Detalles de la búsqueda
1.
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone.
Br J Cancer
; 125(8): 1080-1088, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253874
2.
Immune status is prognostic for poor survival in colorectal cancer patients and is associated with tumour hypoxia.
Br J Cancer
; 123(8): 1280-1288, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32684627
3.
Choosing the right strategy based on individualized treatment effect predictions: combination versus sequential chemotherapy in patients with metastatic colorectal cancer.
Acta Oncol
; 58(3): 326-333, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30657353
4.
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.
Lancet Oncol
; 17(12): 1709-1719, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27743922
5.
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial.
Lancet Oncol
; 14(8): 749-59, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23725851
6.
Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer.
Clin Cancer Res
; 29(20): 4153-4165, 2023 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37363997
7.
Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.
Lancet
; 377(9779): 1749-59, 2011 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-21570111
8.
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.
Lancet
; 377(9783): 2103-14, 2011 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-21641636
9.
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.
Lancet Oncol
; 12(7): 642-53, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21641867
10.
Prognostic and Predictive Impact of Primary Tumor Sidedness for Previously Untreated Advanced Colorectal Cancer.
J Natl Cancer Inst
; 113(12): 1705-1713, 2021 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34061178
11.
Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in RAS Wild-Type Metastatic Colorectal Cancer.
Clin Cancer Res
; 27(12): 3422-3431, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33888518
12.
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial.
JAMA Oncol
; 7(6): 869-877, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33983395
13.
In-depth Clinical and Biological Exploration of DNA Damage Immune Response as a Biomarker for Oxaliplatin Use in Colorectal Cancer.
Clin Cancer Res
; 27(1): 288-300, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33028592
14.
Colorectal cancer peritoneal metastases: Biology, treatment and next steps.
Eur J Surg Oncol
; 46(4 Pt A): 675-683, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31806517
15.
Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer.
JAMA Netw Open
; 2(9): e1911750, 2019 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31539075
16.
Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.
Lancet
; 370(9582): 143-152, 2007 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-17630037
17.
Adjuvant bevacizumab in colon cancer: where did we go wrong?
Lancet Oncol
; 13(12): 1176-7, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23168364
18.
Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer.
JAMA Oncol
; 4(4): 564-568, 2018 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29075780
19.
Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database.
Eur J Cancer
; 103: 205-213, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30268921
20.
Personalizing Survival Predictions in Advanced Colorectal Cancer: The ARCAD Nomogram Project.
J Natl Cancer Inst
; 110(6): 638-648, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29267900